ALK and lymphoma: For instance, in lymphoma studies, I1171N and I1171T are reported to be AP26113-resistant [39, 41], and while both appear resistant to ceritinib in NPM-ALK [39, 41], they show sensitivity in EML4-ALK [43, 44, 47, 48].